Clinteract: Interactive Response Technology for Modern Clinical Trials
Clinteract is Sharp’s advanced Interactive Response Technology (IRT) solution, also known as a Randomization and Trial Supply Management (RTSM) platform. Purpose-built to support the complexities of global clinical trials, Clinteract supports key trial functions such as patient randomization, material assignment, blinding control, and clinical supply oversight. Designed with flexibility, real-time control, and seamless integration in mind, Clinteract enables centralized trial management that enhances data integrity and operational consistency across countries, systems, and sites.
Whether your trial involves intricate randomization schemes or multi-country supply chains, Clinteract adapts to meet your needs. The platform simplifies even the most complex protocols while maintaining full regulatory alignment and enabling efficient, compliant execution.
Advanced Patient Randomization & Enrollment
Ensure trial integrity and streamline enrollment with Clinteract’s robust patient randomization capabilities. Built to support trials of all sizes and complexities, Clinteract offers a flexible suite of randomization methodologies tailored to meet protocol-specific needs.
From Permuted Block Design which maintains balance within pre-defined blocks, to Covariant Adaptive Randomization that adjusts dynamically for multiple patient characteristics, the platform enables precise control and optimized allocation.
Clinteract also supports complex visit schedules and multi-stage randomization strategies, making it an ideal solution for adaptive and global trial designs. With Clinteract, you can manage randomization and enrollment with confidence – ensuring unbiased outcomes, accelerating timelines, and enhancing your study’s success from the start.
Efficient Supply Chain Oversight
Effective supply chain management is critical to clinical trial success. Clinteract provides full visibility through a customizable interactive shipment grid, allowing you to track every movement; whether depot-to-depot, depot-to-site, site-to-depot, or site-to-site.
Clinteract ensures complete traceability of drug inventory from initial release to final return or destruction, supporting audit readiness and regulatory compliance. With real-time insights and centralized control, you gain greater oversight, faster decision-making, and seamless supply execution across your global trial landscape.
Designed for the End User
Clinteract is a user-powered IRT platform built for flexibility, adaptability, and real-world usability. User roles are defined during initial requirements gathering, and system actions are tailored accordingly. Wherever possible, control over key parameters is delegated to designated users through – minimizing change controls and streamlining day-to-day management.
Clinical trials evolve, and Clinteract is designed to evolve with them. As protocols are amended and new insights emerge, Clinteract empowers permissioned users to make common updates to study, site, drug management, and administrative settings—without requiring formal change orders. For more significant mid-study modifications, Clinteract’s modular architecture allows your dedicated project team to quickly implement and validate new features, ensuring minimal disruption and continued momentum.
A User-Friendly IRT Experience
At Sharp, we know that user experience matters – especially in the fast-paced, high-stakes environment of clinical trials. That’s why Clinteract is designed to be simple, intuitive, and accessible, regardless of a user’s experience level with clinical trial technology.
With a clean, minimalist interface, intuitive navigation, and patient-centric workflows, Clinteract makes it easy for users to interact confidently with the system.
Our form-based subject-related events mirror the layout and logic of common EDC systems, making the experience familiar and user-friendly. All required data points are captured within a single form – eliminating unnecessary workflows and reducing the chance of confusion or error.
Users can quickly access trial data, consult user manuals, compare depot inventories, review drug lot releases, and more – all while maintaining the study blind and ensuring accuracy and compliance.
